A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates.
Open Access
- 1 September 1984
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 259 (17) , 10793-10800
- https://doi.org/10.1016/s0021-9258(18)90582-x
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.Journal of Clinical Investigation, 1983
- Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer CellsJournal of Clinical Investigation, 1982
- Multiple forms of human dihydrofolate reductase messenger RNAJournal of Molecular Biology, 1982
- Changes in the chain length of folypolyglutamates during liver regenerationLife Sciences, 1982
- Characteristics of membrane transport of methotrexate by cultured human breast cancer cellsBiochemical Pharmacology, 1981
- Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexateBiochemistry, 1980
- Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductasePublished by Elsevier ,1977
- Isolation and biochemical characterization of folate deficient mutants of chinese hamster cellsCell, 1974
- Polygammaglutamyl metabolites of methotrexateBiochemical and Biophysical Research Communications, 1973
- SITES OF ACTION OF AMETHOPTERIN: INTRINSIC AND ACQUIRED DRUG RESISTANCEAnnals of the New York Academy of Sciences, 1971